ibca european rating agency downgraded long term rating fisons drugs scientific equipment company bbb+ bbb the short term rating remains unchanged a2 ibca said fisons profits warnings interim results announced september came four years deteriorating income coverage ratios with limited cash generated operations difficult see long term support large capital rd expenditure come although short term disposals could made ibca said